Progyny, Inc. (PGNY)
NASDAQ: PGNY · Real-Time Price · USD
14.58
+0.60 (4.30%)
Nov 21, 2024, 11:59 AM EST - Market open

Company Description

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States.

Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.

The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment.

In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services.

The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Progyny, Inc.
Progyny logo
Country United States
Founded 2008
IPO Date Oct 25, 2019
Industry Health Information Services
Sector Healthcare
Employees 566
CEO Peter Anevski

Contact Details

Address:
1359 Broadway
New York, New York 10018
United States
Phone 212 888 3124
Website progyny.com

Stock Details

Ticker Symbol PGNY
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
IPO Price $13.00
CIK Code 0001551306
CUSIP Number 74340E103
ISIN Number US74340E1038
Employer ID 27-2220139
SIC Code 8090

Key Executives

Name Position
Michael Sturmer President
Allison Swartz Executive Vice President, General Counsel and Secretary
Steven Leist Chief Technology Officer
James Hart Vice President of Investor Relations
Risa Fisher Chief Marketing Officer
Cassandra Pratt Chief Human Resources Officer
Julie Stadlbauer Chief Business Development Officer
Janet Choi M.D. Member of the Medical Advisory Board and Chief Medical Officer
Arielle Bogorad Senior Vice President of Employer Market Strategy
Katie Higgins Chief Commercial Officer

Latest SEC Filings

Date Type Title
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 12, 2024 10-Q Quarterly Report
Nov 12, 2024 8-K Current Report
Nov 8, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Oct 18, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Sep 18, 2024 8-K Current Report
Sep 5, 2024 UPLOAD Filing
Aug 15, 2024 UPLOAD Filing
Aug 12, 2024 8-K Current Report
Aug 7, 2024 10-Q Quarterly Report